-
1
-
-
0030980497
-
Descriptive epidemiology of cerebral gliomas in France
-
DOI 10.1002/(SICI)1097-0142(19970315)79:6<1195::AID-CNCR19>3.0. CO;2-V
-
Fleury A., Menegoz F., Grosclaude P., Descriptive epidemiology of cerebral gliomas in France Cancer 1997 79 6 1195 1202 (Pubitemid 27118217)
-
(1997)
Cancer
, vol.79
, Issue.6
, pp. 1195-1202
-
-
Fleury, A.1
Menegoz, F.2
Grosclaude, P.3
Daures, J.-P.4
Henry-Amar, M.5
Raverdy, N.6
Schaffer, P.7
Poisson, M.8
Delattre, J.-Y.9
-
2
-
-
33745010017
-
Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial
-
DOI 10.1200/JCO.2005.04.5963
-
Mirimanoff R. O., Gorlia T., Mason W., Van Den Bent M. J., Kortmann R. D., Fisher B., Reni M., Brandes A. A., Curschmann J., Villa S., Cairncross G., Allgeier A., Lacombe D., Stupp R., Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial Journal of Clinical Oncology 2006 24 16 2563 2569 (Pubitemid 46630635)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.16
, pp. 2563-2569
-
-
Mirimanoff, R.-O.1
Gorlia, T.2
Mason, W.3
Van Den Bent, M.J.4
Kortmann, R.-D.5
Fisher, B.6
Reni, M.7
Brandes, A.A.8
Curschmann, J.9
Villa, S.10
Cairncross, G.11
Allgeier, A.12
Lacombe, D.13
Stupp, R.14
-
3
-
-
42449117269
-
Extent of resection and survival in glioblastoma multiforme: Identification of and adjustment for bias
-
Stummer W., Reulen H. J., Meinel T., Pichlmeier U., Schumacher W., Tonn J. C., Rohde V., Oppel F., Turowski B., Woiciechowsky C., Franz K., Pietsch T., Oppel F., Brune A., Lanksch W., Woiciechowsky C., Brock M., Vesper J., Tonn J. C., Goetz C., Gilsbach J. M., Mayfrank L., Oertel M. F., Seifert V., Franz K., Bink A. J. W., Schackert G., Pinzer T., Hassler W., Bani A., Meisel H. J., Kern B. C., Mehdorn H. M., Nabavi A., Brawanski A., Ullrich O. W., Bker D. K., Winking M., Weber F., Langenbach U., Westphal M., Khler U., Arnold H., Knopp U., Grumme T., Stretz T., Stolke D., Wiedemayer H., Turowski B., Pietsch T., Wiestler O. D., Reulen H. J., Stummer W., Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias Neurosurgery 2008 62 3 564 576
-
(2008)
Neurosurgery
, vol.62
, Issue.3
, pp. 564-576
-
-
Stummer, W.1
Reulen, H.J.2
Meinel, T.3
Pichlmeier, U.4
Schumacher, W.5
Tonn, J.C.6
Rohde, V.7
Oppel, F.8
Turowski, B.9
Woiciechowsky, C.10
Franz, K.11
Pietsch, T.12
Oppel, F.13
Brune, A.14
Lanksch, W.15
Woiciechowsky, C.16
Brock, M.17
Vesper, J.18
Tonn, J.C.19
Goetz, C.20
Gilsbach, J.M.21
Mayfrank, L.22
Oertel, M.F.23
Seifert, V.24
Franz, K.25
Bink, A.J.W.26
Schackert, G.27
Pinzer, T.28
Hassler, W.29
Bani, A.30
Meisel, H.J.31
Kern, B.C.32
Mehdorn, H.M.33
Nabavi, A.34
Brawanski, A.35
Ullrich, O.W.36
Bker, D.K.37
Winking, M.38
Weber, F.39
Langenbach, U.40
Westphal, M.41
Khler, U.42
Arnold, H.43
Knopp, U.44
Grumme, T.45
Stretz, T.46
Stolke, D.47
Wiedemayer, H.48
Turowski, B.49
Pietsch, T.50
Wiestler, O.D.51
Reulen, H.J.52
Stummer, W.53
more..
-
4
-
-
33645986455
-
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial
-
Stummer W., Pichlmeier U., Meinel T., Wiestler O. D., Zanella F., Reulen H. J., Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial The Lancet Oncology 2006 7 5 392 401
-
(2006)
The Lancet Oncology
, vol.7
, Issue.5
, pp. 392-401
-
-
Stummer, W.1
Pichlmeier, U.2
Meinel, T.3
Wiestler, O.D.4
Zanella, F.5
Reulen, H.J.6
-
5
-
-
70449523002
-
Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas
-
Stockhammer F., Misch M., Horn P., Koch A., Fonyuy N., Plotkin M., Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas Acta Neurochirurgica 2009 151 11 1377 1383
-
(2009)
Acta Neurochirurgica
, vol.151
, Issue.11
, pp. 1377-1383
-
-
Stockhammer, F.1
Misch, M.2
Horn, P.3
Koch, A.4
Fonyuy, N.5
Plotkin, M.6
-
6
-
-
33644787355
-
Gliadel® wafer in initial surgery for malignant glioma: Long-term follow-up of a multicenter controlled trial
-
DOI 10.1007/s00701-005-0707-z
-
Westphal M., Ram Z., Riddle V., Hilt D., Bortey E., Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial Acta Neurochirurgica 2006 148 3 269 275 (Pubitemid 43341024)
-
(2006)
Acta Neurochirurgica
, vol.148
, Issue.3
, pp. 269-275
-
-
Westphal, M.1
Ram, Z.2
Riddle, V.3
Hilt, D.4
Bortey, E.5
-
7
-
-
77955706783
-
Biodegradable carmustine wafers (Gliadel) alone or in combination with chemoradiotherapy: The French experience
-
Menei P., Metellus P., Parot-Schinkel E., Loiseau H., Capelle L., Jacquet G., Guyotat J., Biodegradable carmustine wafers (Gliadel) alone or in combination with chemoradiotherapy: the French experience Annals of Surgical Oncology 2010 17 7 1740 1746
-
(2010)
Annals of Surgical Oncology
, vol.17
, Issue.7
, pp. 1740-1746
-
-
Menei, P.1
Metellus, P.2
Parot-Schinkel, E.3
Loiseau, H.4
Capelle, L.5
Jacquet, G.6
Guyotat, J.7
-
8
-
-
0027415401
-
Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme
-
Kreth F. W., Warnke P. C., Scheremet R., Ostertag C. B., Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme Journal of Neurosurgery 1993 78 5 762 766 (Pubitemid 23121918)
-
(1993)
Journal of Neurosurgery
, vol.78
, Issue.5
, pp. 762-766
-
-
Kreth, F.W.1
Warnke, P.C.2
Scheremet, R.3
Ostertag, C.B.4
-
9
-
-
0034916566
-
The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours - A prospective study
-
DOI 10.1007/s007010170058
-
Kreth F. W., Muacevic A., Medele R., Bise K., Meyer T., Reulen H. J., The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumoursa prospective study Acta Neurochirurgica 2001 143 6 539 546 (Pubitemid 32662388)
-
(2001)
Acta Neurochirurgica
, vol.143
, Issue.6
, pp. 539-546
-
-
Kreth, F.W.1
Muacevic, A.2
Medele, R.3
Bise, K.4
Meyer, T.5
Reulen, H.-J.6
-
10
-
-
35649001325
-
Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas
-
DOI 10.1002/ijc.23020
-
Grasbon-Frodl E. M., Kreth F. W., Ruiter M., Schnell O., Bise K., Felsberg J., Reifenberger G., Tonn J. C., Kretzschmar H. A., Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas International Journal of Cancer 2007 121 11 2458 2464 (Pubitemid 350022415)
-
(2007)
International Journal of Cancer
, vol.121
, Issue.11
, pp. 2458-2464
-
-
Grasbon-Frodl, E.M.1
Kreth, F.W.2
Ruiter, M.3
Schnell, O.4
Bise, K.5
Felsberg, J.6
Reifenberger, G.7
Tonn, J.-C.8
Kretzschmar, H.A.9
-
11
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
DOI 10.1056/NEJMoa043330
-
Stupp R., Mason W. P., Van Den Bent M. J., Weller M., Fisher B., Taphoorn M. J. B., Belanger K., Brandes A. A., Marosi C., Bogdahn U., Curschmann J., Janzer R. C., Ludwin S. K., Gorlia T., Allgeier A., Lacombe D., Cairncross J. G., Eisenhauer E., Mirimanoff R. O., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma The New England Journal of Medicine 2005 352 10 987 996 (Pubitemid 40349501)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.10
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
Van Den Bent, M.J.3
Weller, M.4
Fisher, B.5
Taphoorn, M.J.B.6
Belanger, K.7
Brandes, A.A.8
Marosi, C.9
Bogdahn, U.10
Curschmann, J.11
Janzer, R.C.12
Ludwin, S.K.13
Gorlia, T.14
Allgeier, A.15
Lacombe, D.16
Cairncross, J.G.17
Eisenhauer, E.18
Mirimanoff, R.O.19
-
12
-
-
65349121788
-
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
-
Stupp R., Hegi M. E., Mason W. P., van den Bent M. J., Taphoorn M. J., Janzer R. C., Ludwin S. K., Allgeier A., Fisher B., Belanger K., Hau P., Brandes A. A., Gijtenbeek J., Marosi C., Vecht C. J., Mokhtari K., Wesseling P., Villa S., Eisenhauer E., Gorlia T., Weller M., Lacombe D., Cairncross J. G., Mirimanoff R. O., Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial The Lancet Oncology 2009 10 5 459 466
-
(2009)
The Lancet Oncology
, vol.10
, Issue.5
, pp. 459-466
-
-
Stupp, R.1
Hegi, M.E.2
Mason, W.P.3
Van Den Bent, M.J.4
Taphoorn, M.J.5
Janzer, R.C.6
Ludwin, S.K.7
Allgeier, A.8
Fisher, B.9
Belanger, K.10
Hau, P.11
Brandes, A.A.12
Gijtenbeek, J.13
Marosi, C.14
Vecht, C.J.15
Mokhtari, K.16
Wesseling, P.17
Villa, S.18
Eisenhauer, E.19
Gorlia, T.20
Weller, M.21
Lacombe, D.22
Cairncross, J.G.23
Mirimanoff, R.O.24
more..
-
13
-
-
20044372154
-
MGMT gene silencing and benefit from temozolomide in glioblastoma
-
DOI 10.1056/NEJMoa043331
-
Hegi M. E., Diserens A. C., Gorlia T., Hamou M. F., De Tribolet N., Weller M., Kros J. M., Hainfellner J. A., Mason W., Mariani L., Bromberg J. E. C., Hau P., Mirimanoff R. O., Cairncross J. G., Janzer R. C., Stupp R., MGMT gene silencing and benefit from temozolomide in glioblastoma The New England Journal of Medicine 2005 352 10 997 1003 (Pubitemid 40349502)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.10
, pp. 997-1003
-
-
Hegi, M.E.1
Diserens, A.-C.2
Gorlia, T.3
Hamou, M.-F.4
De Tribolet, N.5
Weller, M.6
Kros, J.M.7
Hainfellner, J.A.8
Mason, W.9
Mariani, L.10
Bromberg, J.E.C.11
Hau, P.12
Mirimanoff, R.O.13
Cairncross, J.G.14
Janzer, R.C.15
Stupp, R.16
-
14
-
-
33947533746
-
Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma
-
DOI 10.1212/01.wnl.0000255937.27012.ee, PII 0000611420070227000015
-
Hau P., Koch D., Hundsberger T., Marg E., Bauer B., Rudolph R., Rauch M., Brenner A., Rieckmann P., Schuth J., Jauch T., Koch H., Bogdahn U., Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma Neurology 2007 68 9 688 690 (Pubitemid 46667817)
-
(2007)
Neurology
, vol.68
, Issue.9
, pp. 688-690
-
-
Hau, P.1
Koch, D.2
Hundsberger, T.3
Marg, E.4
Bauer, B.5
Rudolph, R.6
Rauch, M.7
Brenner, A.8
Rieckmann, P.9
Schuth, J.10
Jauch, T.11
Koch, H.12
Bogdahn, U.13
-
15
-
-
45849146166
-
'Recurrent' glioblastoma multiforme, when should we reoperate?
-
DOI 10.1080/02688690802182256, PII 793649736
-
Barbagallo G. M. V., Jenkinson M. D., Brodbelt A. R., 'Recurrent' glioblastoma multiforme, when should we reoperate? British Journal of Neurosurgery 2008 22 3 452 455 (Pubitemid 351878614)
-
(2008)
British Journal of Neurosurgery
, vol.22
, Issue.3
, pp. 452-455
-
-
Barbagallo, G.M.V.1
Jenkinson, M.D.2
Brodbelt, A.R.3
-
16
-
-
42049111663
-
Repeated surgery for glioblastoma multiforme: Only in combination with other salvage therapy
-
Mandl E. S., Dirven C. M. F., Buis D. R., Postma T. J., Vandertop W. P., Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy Surgical Neurology 2008 69 5 506 509
-
(2008)
Surgical Neurology
, vol.69
, Issue.5
, pp. 506-509
-
-
Mandl, E.S.1
Dirven, C.M.F.2
Buis, D.R.3
Postma, T.J.4
Vandertop, W.P.5
-
17
-
-
48749133554
-
Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas
-
Combs S. E., Bischof M., Welzel T., Hof H., Oertel S., Debus J., Schulz-Ertner D., Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas Journal of Neuro-Oncology 2008 89 2 205 210
-
(2008)
Journal of Neuro-Oncology
, vol.89
, Issue.2
, pp. 205-210
-
-
Combs, S.E.1
Bischof, M.2
Welzel, T.3
Hof, H.4
Oertel, S.5
Debus, J.6
Schulz-Ertner, D.7
-
18
-
-
69949136127
-
Survival following stereotactic radiosurgery for newly diagnosed and recurrent glioblastoma multiforme: A multicenter experience
-
Villavicencio A. T., Burneikiene S., Romanelli P., Fariselli L., McNeely L., Lipani J. D., Chang S. D., Nelson E. L., McIntyre M., Broggi G., Adler J. R., Survival following stereotactic radiosurgery for newly diagnosed and recurrent glioblastoma multiforme: a multicenter experience Neurosurgical Review 2009 32 4 417 424
-
(2009)
Neurosurgical Review
, vol.32
, Issue.4
, pp. 417-424
-
-
Villavicencio, A.T.1
Burneikiene, S.2
Romanelli, P.3
Fariselli, L.4
McNeely, L.5
Lipani, J.D.6
Chang, S.D.7
Nelson, E.L.8
McIntyre, M.9
Broggi, G.10
Adler, J.R.11
-
19
-
-
78649628169
-
FDA accelerated approval benefits glioblastoma
-
Cloughesy T., FDA accelerated approval benefits glioblastoma The Lancet Oncology 2010 11 12 1120
-
(2010)
The Lancet Oncology
, vol.11
, Issue.12
, pp. 1120
-
-
Cloughesy, T.1
-
20
-
-
33947191055
-
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma
-
DOI 10.1158/1078-0432.CCR-06-2309
-
Vredenburgh J. J., Desjardins A., Herndon J. E., Dowell J. M., Reardon D. A., Quinn J. A., Rich J. N., Sathornsumetee S., Gururangan S., Wagner M., Bigner D. D., Friedman A. H., Friedman H. S., Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma Clinical Cancer Research 2007 13 4 1253 1259 (Pubitemid 46424067)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.4
, pp. 1253-1259
-
-
Vredenburgh, J.J.1
Desjardins, A.2
Herndon II, J.E.3
Dowell, J.M.4
Reardon, D.A.5
Quinn, J.A.6
Rich, J.N.7
Sathornsumetee, S.8
Gururangan, S.9
Wagner, M.10
Bigner, D.D.11
Friedman, A.H.12
Friedman, H.S.13
-
21
-
-
36049037819
-
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
-
DOI 10.1200/JCO.2007.12.2440
-
Vredenburgh J. J., Desjardins A., Herndon J. E., Marcello J., Reardon D. A., Quinn J. A., Rich J. N., Sathornsumetee S., Gururangan S., Sampson J., Wagner M., Bailey L., Bigner D. D., Friedman A. H., Friedman H. S., Bevacizumab plus irinotecan in recurrent glioblastoma multiforme Journal of Clinical Oncology 2007 25 30 4722 4729 (Pubitemid 350086473)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.30
, pp. 4722-4729
-
-
Vredenburgh, J.J.1
Desjardins, A.2
Herndon II, J.E.3
Marcello, J.4
Reardon, D.A.5
Quinn, J.A.6
Rich, J.N.7
Sathornsumetee, S.8
Gururangan, S.9
Sampson, J.10
Wagner, M.11
Bailey, L.12
Bigner, D.D.13
Friedman, A.H.14
Friedman, H.S.15
-
22
-
-
70350461699
-
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma
-
Friedman H. S., Prados M. D., Wen P. Y., Mikkelsen T., Schiff D., Abrey L. E., Yung W. K. A., Paleologos N., Nicholas M. K., Jensen R., Vredenburgh J., Huang J., Zheng M., Cloughesy T., Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma Journal of Clinical Oncology 2009 27 28 4733 4740
-
(2009)
Journal of Clinical Oncology
, vol.27
, Issue.28
, pp. 4733-4740
-
-
Friedman, H.S.1
Prados, M.D.2
Wen, P.Y.3
Mikkelsen, T.4
Schiff, D.5
Abrey, L.E.6
Yung, W.K.A.7
Paleologos, N.8
Nicholas, M.K.9
Jensen, R.10
Vredenburgh, J.11
Huang, J.12
Zheng, M.13
Cloughesy, T.14
-
23
-
-
33750432843
-
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: Phase II study from Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
-
DOI 10.1038/sj.bjc.6603376, PII 6603376
-
Brandes A. A., Tosoni A., Cavallo G., Bertorelle R., Gioia V., Franceschi E., Biscuola M., Blatt V., Crin L., Ermani M., Temozolomide 3weeks on and 1week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO) British Journal of Cancer 2006 95 9 1155 1160 (Pubitemid 44658477)
-
(2006)
British Journal of Cancer
, vol.95
, Issue.9
, pp. 1155-1160
-
-
Brandes, A.A.1
Tosoni, A.2
Cavallo, G.3
Bertorelle, R.4
Gioia, V.5
Franceschi, E.6
Biscuola, M.7
Blatt, V.8
Crino, L.9
Ermani, M.10
-
24
-
-
34548213721
-
Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma
-
DOI 10.1200/JCO.2007.10.7722
-
Wick A., Felsberg J., Steinbach J. P., Herrlinger U., Platten M., Blaschke B., Meyermann R., Reifenberger G., Weller M., Wick W., Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma Journal of Clinical Oncology 2007 25 22 3357 3361 (Pubitemid 47325623)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.22
, pp. 3357-3361
-
-
Wick, A.1
Felsberg, J.2
Steinbach, J.P.3
Herrlinger, U.4
Platten, M.5
Blaschke, B.6
Meyermann, R.7
Reifenberger, G.8
Weller, M.9
Wick, W.10
-
25
-
-
55749094160
-
Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: The "rescue" approach
-
Perry J. R., Rizek P., Cashman R., Morrison M., Morrison T., Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach Cancer 2008 113 8 2152 2157
-
(2008)
Cancer
, vol.113
, Issue.8
, pp. 2152-2157
-
-
Perry, J.R.1
Rizek, P.2
Cashman, R.3
Morrison, M.4
Morrison, T.5
-
26
-
-
78449288666
-
Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma
-
Stockhammer F., Misch M., Koch A., Czabanka M., Plotkin M., Blechschmidt C., Tuettenberg J., Vajkoczy P., Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma Journal of Neuro-Oncology 2010 100 3 407 415
-
(2010)
Journal of Neuro-Oncology
, vol.100
, Issue.3
, pp. 407-415
-
-
Stockhammer, F.1
Misch, M.2
Koch, A.3
Czabanka, M.4
Plotkin, M.5
Blechschmidt, C.6
Tuettenberg, J.7
Vajkoczy, P.8
-
27
-
-
0344236156
-
Salvage Therapy in Patients with Glioblastoma: Is There any Benefit?
-
DOI 10.1002/cncr.11845
-
Hau P., Baumgart U., Pfeifer K., Bock A., Jauch T., Dietrich J., Fabel K., Grauer O., Wismeth C., Klinkhammer-Schalke M., Allguer M., Schuierer G., Koch H., Schlaier J., Ulrich W., Brawanski A., Bogdahn U., Steinbrecher A., Salvage therapy in patients with glioblastoma: is there any benefit? Cancer 2003 98 12 2678 2686 (Pubitemid 37509533)
-
(2003)
Cancer
, vol.98
, Issue.12
, pp. 2678-2686
-
-
Hau, P.1
Baumgart, U.2
Pfeifer, K.3
Bock, A.4
Jauch, T.5
Dietrich, J.6
Fabel, K.7
Grauer, O.8
Wismeth, C.9
Klinkhammer-Schalke, M.10
Allgauer, M.11
Schuierer, G.12
Koch, H.13
Schlaier, J.14
Ulrich, W.15
Brawanski, A.16
Bogdahn, U.17
Steinbrecher, A.18
-
28
-
-
0033231490
-
Immune privilege: Keeping an eye on natural killer T cells
-
DOI 10.1084/jem.190.9.1197
-
Hong S., Van Kaer L., Immune privilege: keeping an eye on natural killer T cells The Journal of Experimental Medicine 1999 190 9 1197 1200 (Pubitemid 29522204)
-
(1999)
Journal of Experimental Medicine
, vol.190
, Issue.9
, pp. 1197-1200
-
-
Hong, S.1
Van Kaer, L.2
-
29
-
-
70450232004
-
Clinical applications of a peptide-based vaccine for glioblastoma
-
Kanaly C. W., Ding D., Heimberger A. B., Sampson J. H., Clinical applications of a peptide-based vaccine for glioblastoma Neurosurgery Clinics of North America 2010 21 1 95 109
-
(2010)
Neurosurgery Clinics of North America
, vol.21
, Issue.1
, pp. 95-109
-
-
Kanaly, C.W.1
Ding, D.2
Heimberger, A.B.3
Sampson, J.H.4
-
30
-
-
79959949897
-
Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer
-
Thara E., Dorff T. B., Pinski J. K., Quinn D. I., Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer Maturitas 2011 69 4 296 303
-
(2011)
Maturitas
, vol.69
, Issue.4
, pp. 296-303
-
-
Thara, E.1
Dorff, T.B.2
Pinski, J.K.3
Quinn, D.I.4
-
31
-
-
0022641036
-
Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: Phase I trial
-
4 II
-
Jacobs S. K., Wilson D. J., Kornblith P. L., Grimm E. A., Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial Cancer Research 1986 46 4 2101 2104 (Pubitemid 16117915)
-
(1986)
Cancer Research
, vol.46
, pp. 2101-2104
-
-
Jacobs, S.K.1
Wilson, D.J.2
Kornblith, P.L.3
Grimm, E.A.4
-
32
-
-
0023813406
-
Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2
-
Merchant R. E., Grant A. J., Merchant L. H., Young H. F., Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2 Cancer 1988 62 4 665 671
-
(1988)
Cancer
, vol.62
, Issue.4
, pp. 665-671
-
-
Merchant, R.E.1
Grant, A.J.2
Merchant, L.H.3
Young, H.F.4
-
33
-
-
0024510754
-
Intratumoral LAK cell and interleukin-2 therapy of human gliomas
-
Barba D., Saris S. C., Holder C., Rosenberg S. A., Oldfield E. H., Intratumoral LAK cell and interleukin-2 therapy of human gliomas Journal of Neurosurgery 1989 70 2 175 182 (Pubitemid 19051711)
-
(1989)
Journal of Neurosurgery
, vol.70
, Issue.2
, pp. 175-182
-
-
Barba, D.1
Saris, S.C.2
Holder, C.3
Rosenberg, S.A.4
Oldfield, E.H.5
-
34
-
-
0025974603
-
Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy
-
Lillehei K. O., Mitchell D. H., Johnson S. D., McCleary E. L., Kruse C. A., Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy Neurosurgery 1991 28 1 16 23
-
(1991)
Neurosurgery
, vol.28
, Issue.1
, pp. 16-23
-
-
Lillehei, K.O.1
Mitchell, D.H.2
Johnson, S.D.3
McCleary, E.L.4
Kruse, C.A.5
-
35
-
-
0027314032
-
Therapy of recurrent high grade gliomas with surgery, and autologous mitogen activated IL-2 stimulated killer (MAK) lymphocytes: I. Enhancement of MAK lytic activity and cytokine production by PHA and clinical use of PHA
-
Jeffes E. W. B. III, Beamer Y. B., Jacques S., Silberman R. S., Vayuvegula B., Gupta S., Coss J. S., Yamamoto R. S., Granger G. A., Therapy of recurrent high grade gliomas with surgery, and autologous mitogen activated IL-2 stimulated killer (MAK) lymphocytes: I. Enhancement of MAK lytic activity and cytokine production by PHA and clinical use of PHA Journal of Neuro-Oncology 1993 15 2 141 155 (Pubitemid 23136029)
-
(1993)
Journal of Neuro-Oncology
, vol.15
, Issue.2
, pp. 141-155
-
-
Jeffes III, E.W.B.1
Beamer, Y.B.2
Jacques, S.3
Silberman, R.S.4
Vayuvegula, B.5
Gupta, S.6
Coss, J.S.7
Yamamoto, R.S.8
Granger, G.A.9
-
36
-
-
0027139196
-
Local immunotherapy of recurrent glioblastoma multiforme by intracerebral perfusion of interleukin-2 and LAK cells
-
Blancher A., Roubinet F., Grancher A. S., Tremoulet M., Bonate A., Delisle M. B., Calot J. P., Pourreau C., Franks C., Ducos J., Rascol A., Clanet M., Local immunotherapy of recurrent glioblastoma multiforme by intracerebral perfusion of interleukin-2 and LAK cells European Cytokine Network 1993 4 5 331 341 (Pubitemid 24001545)
-
(1993)
European Cytokine Network
, vol.4
, Issue.5
, pp. 331-341
-
-
Blancher, A.1
Roubinet, F.2
Grancher, A.S.3
Tremoulet, M.4
Bonate, A.5
Delisle, M.-B.6
Calot, J.-P.7
Pourreau, C.8
Franks, C.9
Ducos, J.10
Rascol, A.11
Clanet, M.12
-
37
-
-
0028108663
-
Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients
-
Boiardi A., Silvani A., Adelchi Ruffini P., Rivoltini L., Parmiani G., Broggi G., Salmaggi A., Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients Cancer Immunology Immunotherapy 1994 39 3 193 197 (Pubitemid 24298394)
-
(1994)
Cancer Immunology Immunotherapy
, vol.39
, Issue.3
, pp. 193-197
-
-
Boiardi, A.1
Silvani, A.2
Adelchi Ruffini, P.3
Rivoltini, L.4
Parmiani, G.5
Broggi, G.6
Salmaggi, A.7
-
38
-
-
0029145309
-
Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma
-
Hayes R. L., Koslow M., Hiesiger E. M., Hymes K. B., Hochster H. S., Moore E. J., Pierz D. M., Chen D. K., Budzilovich G. N., Ransohoff J., Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma Cancer 1995 76 5 840 852
-
(1995)
Cancer
, vol.76
, Issue.5
, pp. 840-852
-
-
Hayes, R.L.1
Koslow, M.2
Hiesiger, E.M.3
Hymes, K.B.4
Hochster, H.S.5
Moore, E.J.6
Pierz, D.M.7
Chen, D.K.8
Budzilovich, G.N.9
Ransohoff, J.10
-
39
-
-
0030065695
-
Adoptive immimotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrentmalignant primary brain tumors
-
Sankhla S. K., Nadkarni J. S., Bhagwati S. N., Adoptive immimotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrentmalignant primary brain tumors Journal of Neuro-Oncology 1995 27 2 133 140
-
(1995)
Journal of Neuro-Oncology
, vol.27
, Issue.2
, pp. 133-140
-
-
Sankhla, S.K.1
Nadkarni, J.S.2
Bhagwati, S.N.3
-
40
-
-
0034978815
-
Adoptive cellular immunotherapy for the treatment of malignant gliomas
-
DOI 10.1016/S1040-8428(01)00122-6, PII S1040842801001226
-
Hayes R. L., Arbit E., Odaimi M., Pannullo S., Scheff R., Kravchinskiy D., Zaroulis C., Adoptive cellular immunotherapy for the treatment of malignant gliomas Critical Reviews in Oncology/Hematology 2001 39 1-2 31 42 (Pubitemid 32551987)
-
(2001)
Critical Reviews in Oncology/Hematology
, vol.39
, Issue.1-2
, pp. 31-42
-
-
Hayes, R.L.1
Arbit, E.2
Odaimi, M.3
Pannullo, S.4
Scheff, R.5
Kravchinskiy, D.6
Zaroulis, C.7
-
41
-
-
4344689067
-
Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma
-
Dillman R. O., Duma C. M., Schiltz P. M., DePriest C., Ellis R. A., Okamoto K., Beutel L. D., De Leon C., Chico S., Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma Journal of Immunotherapy 2004 27 5 398 404 (Pubitemid 39121929)
-
(2004)
Journal of Immunotherapy
, vol.27
, Issue.5
, pp. 398-404
-
-
Dillman, R.O.1
Duma, C.M.2
Schiltz, P.M.3
DePriest, C.4
Ellis, R.A.5
Okamoto, K.6
Beutel, L.D.7
De Leon, C.8
Chico, S.9
-
42
-
-
70350532587
-
Intralesional lymphokine-activated killer cells as adjuvant therapy for primary glioblastoma
-
Dillman R. O., Duma C. M., Ellis R. A., Cornforth A. N., Schiltz P. M., Sharp S. L., Depriest M. C., Intralesional lymphokine-activated killer cells as adjuvant therapy for primary glioblastoma Journal of Immunotherapy 2009 32 9 914 919
-
(2009)
Journal of Immunotherapy
, vol.32
, Issue.9
, pp. 914-919
-
-
Dillman, R.O.1
Duma, C.M.2
Ellis, R.A.3
Cornforth, A.N.4
Schiltz, P.M.5
Sharp, S.L.6
Depriest, M.C.7
-
43
-
-
0030034580
-
Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with Grade III/IV astrocytoma
-
Holladay F. P., Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with Grade III/IV astrocytoma Journal of Neuro-Oncology 1996 27 2 179 189 (Pubitemid 26052654)
-
(1996)
Journal of Neuro-Oncology
, vol.27
, Issue.2
, pp. 179-189
-
-
Holladay, F.P.1
-
44
-
-
0031832638
-
Systemic T cell adoptive immunotherapy of malignant gliomas
-
Plautz G. E., Barnett G. H., Miller D. W., Cohen B. H., Prayson R. A., Krauss J. C., Luciano M., Kangisser D. B., Shu S., Systemic T cell adoptive immunotherapy of malignant gliomas Journal of Neurosurgery 1998 89 1 42 51 (Pubitemid 28285921)
-
(1998)
Journal of Neurosurgery
, vol.89
, Issue.1
, pp. 42-51
-
-
Plautz, G.E.1
Barnett, G.H.2
Miller, D.W.3
Cohen, B.H.4
Prayson, R.A.5
Krauss, J.C.6
Luciano, M.7
Kangisser, D.B.8
Shu, S.9
-
45
-
-
0034044202
-
T cell adoptive immunotherapy of newly diagnosed gliomas
-
Plautz G. E., Miller D. W., Barnett G. H., Stevens G. H. J., Maffett S., Kim J., Cohen P. A., Shu S., T cell adoptive immunotherapy of newly diagnosed gliomas Clinical Cancer Research 2000 6 6 2209 2218 (Pubitemid 30399186)
-
(2000)
Clinical Cancer Research
, vol.6
, Issue.6
, pp. 2209-2218
-
-
Plautz, G.E.1
Miller, D.W.2
Barnett, G.H.3
Stevens, G.H.J.4
Maffett, S.5
Kim, J.6
Cohen, P.A.7
Shu, S.8
-
46
-
-
0033781501
-
A pilot study of autologous cancer cell vaccination and cellular immunotherapy using anti-CD3 stimulated lymphocytes in patients with recurrent grade III/IV astrocytoma
-
Wood G. W., Holladay F. P., Turner T., Wang Y. Y., Chiga M., A pilot study of autologous cancer cell vaccination and cellular immunotherapy using anti-CD3 stimulated lymphocytes in patients with recurrent grade III/IV astrocytoma Journal of Neuro-Oncology 2000 48 2 113 120
-
(2000)
Journal of Neuro-Oncology
, vol.48
, Issue.2
, pp. 113-120
-
-
Wood, G.W.1
Holladay, F.P.2
Turner, T.3
Wang, Y.Y.4
Chiga, M.5
-
47
-
-
33746816721
-
Adoptive immunotherapy in patients with recurrent malignant glioma: Preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes
-
Sloan A. E., Dansey R., Zamorano L., Barger G., Hamm C., Diaz F., Baynes R., Wood G., Adoptive immunotherapy in patients with recurrent malignant glioma: preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes Neurosurgical Focus 2000 9 6 e9
-
(2000)
Neurosurgical Focus
, vol.9
, Issue.6
, pp. 9
-
-
Sloan, A.E.1
Dansey, R.2
Zamorano, L.3
Barger, G.4
Hamm, C.5
Diaz, F.6
Baynes, R.7
Wood, G.8
-
48
-
-
0030694252
-
Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2
-
DOI 10.1007/s002620050405
-
Kruse C. A., Cepeda L., Owens B., Johnson S. D., Stears J., Lillehei K. O., Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2 Cancer Immunology Immunotherapy 1997 45 2 77 87 (Pubitemid 27497682)
-
(1997)
Cancer Immunology Immunotherapy
, vol.45
, Issue.2
, pp. 77-87
-
-
Kruse, C.A.1
Cepeda, L.2
Owens, B.3
Johnson, S.D.4
Stears, J.5
Lillehei, K.O.6
-
49
-
-
0033506158
-
Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas
-
DOI 10.1023/A:1006293606710
-
Quattrocchi K. B., Miller C. H., Cush S., Bernard S. A., Dull S. T., Smith M., Gudeman S., Varia M. A., Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas Journal of Neuro-Oncology 1999 45 2 141 157 (Pubitemid 30197728)
-
(1999)
Journal of Neuro-Oncology
, vol.45
, Issue.2
, pp. 141-157
-
-
Quattrocchi, K.B.1
Miller, C.H.2
Cush, S.3
Bernard, S.A.4
Dull, S.T.5
Smith, M.6
Gudeman, S.7
Varia, M.A.8
-
50
-
-
37549047236
-
Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics
-
DOI 10.1007/s00262-007-0387-z
-
Kronik N., Kogan Y., Vainstein V., Agur Z., Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics Cancer Immunology, Immunotherapy 2008 57 3 425 439 (Pubitemid 50007307)
-
(2008)
Cancer Immunology, Immunotherapy
, vol.57
, Issue.3
, pp. 425-439
-
-
Kronik, N.1
Kogan, Y.2
Vainstein, V.3
Agur, Z.4
-
51
-
-
0028905079
-
Interleukin-2 gene therapy in a patient with glioblastoma
-
Sobol R. E., Fakhrai H., Shawler D., Gjerset R., Dorigo O., Carson C., Khaleghi T., Koziol J., Shiftan T. A., Royston I., Interleukin-2 gene therapy in a patient with glioblastoma Gene Therapy 1995 2 2 164 167
-
(1995)
Gene Therapy
, vol.2
, Issue.2
, pp. 164-167
-
-
Sobol, R.E.1
Fakhrai, H.2
Shawler, D.3
Gjerset, R.4
Dorigo, O.5
Carson, C.6
Khaleghi, T.7
Koziol, J.8
Shiftan, T.A.9
Royston, I.10
-
52
-
-
0034784610
-
Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme
-
DOI 10.1023/A:1011856406683
-
Schneider T., Gerhards R., Kirches E., Firsching R., Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme Journal of Neuro-Oncology 2001 53 1 39 46 (Pubitemid 32936658)
-
(2001)
Journal of Neuro-Oncology
, vol.53
, Issue.1
, pp. 39-46
-
-
Schneider, T.1
Gerhards, R.2
Kirches, E.3
Firsching, R.4
-
53
-
-
0035871490
-
Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas
-
Andrews D. W., Resnicoff M., Flanders A. E., Kenyon L., Curtis M., Merli G., Baserga R., Iliakis G., Aiken R. D., Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas Journal of Clinical Oncology 2001 19 8 2189 2200 (Pubitemid 32366973)
-
(2001)
Journal of Clinical Oncology
, vol.19
, Issue.8
, pp. 2189-2200
-
-
Andrews, D.W.1
Resnicoff, M.2
Flanders, A.E.3
Kenyon, L.4
Curtis, M.5
Merli, G.6
Baserga, R.7
Iliakis, G.8
Aiken, R.D.9
-
54
-
-
0043065333
-
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: Preliminary observations in a patient with a favorable response to therapy
-
DOI 10.1023/A:1024969422010
-
Okada H., Lieberman F. S., Edington H. D., Witham T. F., Wargo M. J., Cai Q., Elder E. H., Whiteside T. L., Schold S. C., Pollack I. F., Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy Journal of Neuro-Oncology 2003 64 1-2 13 20 (Pubitemid 36992456)
-
(2003)
Journal of Neuro-Oncology
, vol.64
, Issue.1-2
, pp. 13-20
-
-
Okada, H.1
Lieberman, F.S.2
Edington, H.D.3
Witham, T.F.4
Wargo, M.J.5
Cai, Q.6
Elder, E.H.7
Whiteside, T.L.8
Schold Jr., S.C.9
Pollack, I.F.10
-
55
-
-
16544392098
-
Antitumor vaccination of patients with glioblastoma multiforme: A pilot study to assess feasibility, safety, and clinical benefits
-
DOI 10.1200/JCO.2004.09.038
-
Steiner H. H., Bonsanto M. M., Beckhove P., Brysch M., Geletneky K., Ahmadi R., Schuele-Freyer R., Kremer P., Ranaie G., Matejic D., Bauer H., Kiessling M., Kunze S., Schirrmacher V., Herold-Mende C., Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefits Journal of Clinical Oncology 2004 22 21 4272 4281 (Pubitemid 41185148)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.21
, pp. 4272-4281
-
-
Steiner, H.H.1
Bonsanto, M.M.2
Beckhove, P.3
Brysch, M.4
Geletneky, K.5
Ahmadi, R.6
Schuele-Freyer, R.7
Kremer, P.8
Ranaie, G.9
Matejic, D.10
Bauer, H.11
Kiessling, M.12
Kunze, S.13
Schirrmacher, V.14
Herold-Mende, C.15
-
56
-
-
33646860113
-
Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas
-
DOI 10.1007/s11060-005-9058-0
-
Parney I. F., Chang L. J., Farr-Jones M. A., Hao C., Smylie M., Petruk K. C., Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas Journal of Neuro-Oncology 2006 78 1 71 80 (Pubitemid 43786663)
-
(2006)
Journal of Neuro-Oncology
, vol.78
, Issue.1
, pp. 71-80
-
-
Parney, I.F.1
Chang, L.-J.2
Farr-Jones, M.A.3
Hao, C.4
Smylie, M.5
Petruk, K.C.6
-
57
-
-
34347238993
-
Clinical trial of autologous formalin-fixed tumor vaccine for glioblastoma multiforme patients
-
DOI 10.1111/j.1349-7006.2007.00518.x
-
Ishikawa E., Tsuboi K., Yamamoto T., Muroi A., Takano S., Enomoto T., Matsumura A., Ohno T., Clinical trial of autologous formalin-fixed tumor vaccine for glioblastoma multiforme patients Cancer Science 2007 98 8 1226 1233 (Pubitemid 46993543)
-
(2007)
Cancer Science
, vol.98
, Issue.8
, pp. 1226-1233
-
-
Ishikawa, E.1
Tsuboi, K.2
Yamamoto, T.3
Muroi, A.4
Takano, S.5
Enomoto, T.6
Matsumura, A.7
Ohno, T.8
-
58
-
-
77952548405
-
Autologous tumor cell vaccination plus infusion of GM-CSF by a programmable pump in the treatment of recurrent malignant gliomas
-
Clavreul A., Piard N., Tanguy J. Y., Gamelin E., Rousselet M. C., Leynia P., Menei P., Autologous tumor cell vaccination plus infusion of GM-CSF by a programmable pump in the treatment of recurrent malignant gliomas Journal of Clinical Neuroscience 2010 17 7 842 848
-
(2010)
Journal of Clinical Neuroscience
, vol.17
, Issue.7
, pp. 842-848
-
-
Clavreul, A.1
Piard, N.2
Tanguy, J.Y.3
Gamelin, E.4
Rousselet, M.C.5
Leynia, P.6
Menei, P.7
-
59
-
-
0034041033
-
Immunobiology of dendritic cells
-
DOI 10.1146/annurev.immunol.18.1.767
-
Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y. J., Pulendran B., Palucka K., Immunobiology of dendritic cells Annual Review of Immunology 2000 18 767 811 (Pubitemid 30365397)
-
(2000)
Annual Review of Immunology
, vol.18
, pp. 767-811
-
-
Banchereau, J.1
Briere, F.2
Caux, C.3
Davoust, J.4
Lebecque, S.5
Liu, Y.-J.6
Pulendran, B.7
Palucka, K.8
-
60
-
-
34848837386
-
Taking dendritic cells into medicine
-
DOI 10.1038/nature06175, PII NATURE06175
-
Steinman R. M., Banchereau J., Taking dendritic cells into medicine Nature 2007 449 7161 419 426 (Pubitemid 47509552)
-
(2007)
Nature
, vol.449
, Issue.7161
, pp. 419-426
-
-
Steinman, R.M.1
Banchereau, J.2
-
61
-
-
79951978155
-
Induction of CD8 + T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with -type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma
-
Okada H., Kalinski P., Ueda R., Induction of CD8 + T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with -type 1 polarized dendritic cells and polyinosinic- polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma Journal of Clinical Oncology 2011 29 3 330 336
-
(2011)
Journal of Clinical Oncology
, vol.29
, Issue.3
, pp. 330-336
-
-
Okada, H.1
Kalinski, P.2
Ueda, R.3
-
62
-
-
79952711945
-
Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy
-
Prins R. M., Soto H., Konkankit V., Odesa S. K., Eskin A., Yong W. H., Nelson S. F., Liau L. M., Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy Clinical Cancer Research 2011 17 6 1603 1615
-
(2011)
Clinical Cancer Research
, vol.17
, Issue.6
, pp. 1603-1615
-
-
Prins, R.M.1
Soto, H.2
Konkankit, V.3
Odesa, S.K.4
Eskin, A.5
Yong, W.H.6
Nelson, S.F.7
Liau, L.M.8
-
63
-
-
77956061272
-
Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: A pilot study
-
Ardon H., Van Gool S., Lopes I. S., Maes W., Sciot R., Wilms G., Demaerel P., Bijttebier P., Claes L., Goffin J., Van Calenbergh F., De Vleeschouwer S., Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study Journal of Neuro-Oncology 2010 99 2 261 272
-
(2010)
Journal of Neuro-Oncology
, vol.99
, Issue.2
, pp. 261-272
-
-
Ardon, H.1
Van Gool, S.2
Lopes, I.S.3
Maes, W.4
Sciot, R.5
Wilms, G.6
Demaerel, P.7
Bijttebier, P.8
Claes, L.9
Goffin, J.10
Van Calenbergh, F.11
De Vleeschouwer, S.12
-
64
-
-
77649123099
-
Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours
-
Ardon H., De Vleeschouwer S., Van Calenbergh F., Claes L., Kramm C. M., Rutkowski S., Wolff J. E. A., Van Gool S. W., Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours Pediatric Blood and Cancer 2010 54 4 519 525
-
(2010)
Pediatric Blood and Cancer
, vol.54
, Issue.4
, pp. 519-525
-
-
Ardon, H.1
De Vleeschouwer, S.2
Van Calenbergh, F.3
Claes, L.4
Kramm, C.M.5
Rutkowski, S.6
Wolff, J.E.A.7
Van Gool, S.W.8
-
65
-
-
70350236627
-
An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
-
Sampson J. H., Archer G. E., Mitchell D. A., Heimberger A. B., Herndon J. E., Lally-Goss D., McGehee-Norman S., Paolino A., Reardon D. A., Friedman A. H., Friedman H. S., Bigner D. D., An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme Molecular Cancer Therapeutics 2009 8 10 2773 2779
-
(2009)
Molecular Cancer Therapeutics
, vol.8
, Issue.10
, pp. 2773-2779
-
-
Sampson, J.H.1
Archer, G.E.2
Mitchell, D.A.3
Heimberger, A.B.4
Herndon, J.E.5
Lally-Goss, D.6
McGehee-Norman, S.7
Paolino, A.8
Reardon, D.A.9
Friedman, A.H.10
Friedman, H.S.11
Bigner, D.D.12
-
66
-
-
49649113879
-
Postoperative adjuvant dendritic cellbased immunotherapy in patients with relapsed glioblastoma multiforme
-
De Vleeschouwer S., Fieuws S., Rutkowski S., Van Calenbergh F., Van Loon J., Goffin J., Sciot R., Wilms G., Demaerel P., Warmuth-Metz M., Soerensen N., Wolff J. E. A., Wagner S., Kaempgen E., Van Gool S. W., Postoperative adjuvant dendritic cellbased immunotherapy in patients with relapsed glioblastoma multiforme Clinical Cancer Research 2008 14 10 3098 3104
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.10
, pp. 3098-3104
-
-
De Vleeschouwer, S.1
Fieuws, S.2
Rutkowski, S.3
Van Calenbergh, F.4
Van Loon, J.5
Goffin, J.6
Sciot, R.7
Wilms, G.8
Demaerel, P.9
Warmuth-Metz, M.10
Soerensen, N.11
Wolff, J.E.A.12
Wagner, S.13
Kaempgen, E.14
Van Gool, S.W.15
-
67
-
-
48649096955
-
Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients
-
Wheeler C. J., Black K. L., Liu G., Mazer M., Zhang X. X., Pepkowitz S., Goldfinger D., Ng H., Irvin D., Yu J. S., Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients Cancer Research 2008 68 14 5955 5964
-
(2008)
Cancer Research
, vol.68
, Issue.14
, pp. 5955-5964
-
-
Wheeler, C.J.1
Black, K.L.2
Liu, G.3
Mazer, M.4
Zhang, X.X.5
Pepkowitz, S.6
Goldfinger, D.7
Ng, H.8
Irvin, D.9
Yu, J.S.10
-
68
-
-
20344372430
-
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: Results of a clinical phase I/II trial
-
DOI 10.1158/1078-0432.CCR-05-0120
-
Yamanaka R., Homma J., Yajima N., Tsuchiya N., Sano M., Kobayashi T., Yoshida S., Abe T., Narita M., Takahashi M., Tanaka R., Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial Clinical Cancer Research 2005 11 11 4160 4167 (Pubitemid 40791581)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.11
, pp. 4160-4167
-
-
Yamanaka, R.1
Homma, J.2
Yajima, N.3
Tsuchiya, N.4
Sano, M.5
Kobayashi, T.6
Yoshida, S.7
Abe, T.8
Narita, M.9
Takahashi, M.10
Tanaka, R.11
-
69
-
-
23044479028
-
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
-
DOI 10.1158/1078-0432.CCR-05-0464
-
Liau L. M., Prins R. M., Kiertscher S. M., Odesa S. K., Kremen T. J., Giovannone A. J., Lin J. W., Chute D. J., Mischet P. S., Cloughesy T. F., Roth M. D., Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment Clinical Cancer Research 2005 11 15 5515 5525 (Pubitemid 41060828)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.15
, pp. 5515-5525
-
-
Liau, L.M.1
Prins, R.M.2
Kiertscher, S.M.3
Odesa, S.K.4
Kremen, T.J.5
Giovannone, A.J.6
Lin, J.-W.7
Chute, D.J.8
Mischet, P.S.9
Cloughesy, T.F.10
Roth, M.D.11
-
70
-
-
3142692559
-
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
-
DOI 10.1158/0008-5472.CAN-03-3505
-
Yu J. S., Liu G., Ying H., Yong W. H., Black K. L., Wheeler C. J., Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma Cancer Research 2004 64 14 4973 4979 (Pubitemid 38924545)
-
(2004)
Cancer Research
, vol.64
, Issue.14
, pp. 4973-4979
-
-
Yu, J.S.1
Liu, G.2
Ying, H.3
Yong, W.H.4
Black, K.L.5
Wheeler, C.J.6
-
71
-
-
7444220033
-
Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12
-
Kikuchi T., Akasaki Y., Abe T., Fukuda T., Saotome H., Ryan J. L., Kufe D. W., Ohno T., Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12 Journal of Immunotherapy 2004 27 6 452 459 (Pubitemid 39447353)
-
(2004)
Journal of Immunotherapy
, vol.27
, Issue.6
, pp. 452-459
-
-
Kikuchi, T.1
Akasaki, Y.2
Abe, T.3
Fukuda, T.4
Saotome, H.5
Ryan, J.L.6
Kufe, D.W.7
Ohno, T.8
-
72
-
-
4344560470
-
Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer
-
DOI 10.1215/S1152851703000668
-
Caruso D. A., Orme L. M., Neale A. M., Radcliff F. J., Armor G. M., Maixner W., Downie P., Hassall T. E., Tang M. L. K., Ashley D. M., Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer Neuro-Oncology 2004 6 3 236 246 (Pubitemid 39136507)
-
(2004)
Neuro-Oncology
, vol.6
, Issue.3
, pp. 236-246
-
-
Caruso, D.A.1
Orme, L.M.2
Neale, A.M.3
Radcliff, F.J.4
Armor, G.M.5
Maixner, W.6
Downie, P.7
Hassall, T.E.8
Tang, M.L.K.9
Ashley, D.M.10
-
73
-
-
4143103624
-
Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
-
DOI 10.1158/1078-0432.CCR-04-0497
-
Wheeler C. J., Das A., Liu G., Yu J. S., Black K. L., Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination Clinical Cancer Research 2004 10 16 5316 5326 (Pubitemid 39100466)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.16
, pp. 5316-5326
-
-
Wheeler, C.J.1
Das, A.2
Liu, G.3
Yu, J.S.4
Black, K.L.5
-
74
-
-
0242329784
-
Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: Results of a clinical phase I/II trial
-
DOI 10.1038/sj.bjc.6601268
-
Yamanaka R., Abe T., Yajima N., Tsuchiya N., Homma J., Kobayashi T., Narita M., Takahashi M., Tanaka R., Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial British Journal of Cancer 2003 89 7 1172 1179 (Pubitemid 37363398)
-
(2003)
British Journal of Cancer
, vol.89
, Issue.7
, pp. 1172-1179
-
-
Yamanaka, R.1
Abe, T.2
Yajima, N.3
Tsuchiya, N.4
Homma, J.5
Kobayashi, T.6
Narita, M.7
Takahashi, M.8
Tanaka, R.9
-
75
-
-
0035107548
-
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration
-
Yu J. S., Wheeler C. J., Zeltzer P. M., Ying H., Finger D. N., Lee P. K., Yong W. H., Incardona F., Thompson R. C., Riedinger M. S., Zhang W., Prins R. M., Black K. L., Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration Cancer Research 2001 61 3 842 847 (Pubitemid 32175145)
-
(2001)
Cancer Research
, vol.61
, Issue.3
, pp. 842-847
-
-
Yu, J.S.1
Wheeler, C.J.2
Zeltzer, P.M.3
Ying, H.4
Finger, D.N.5
Lee, P.K.6
Yong, W.H.7
Incardona, F.8
Thompson, R.C.9
Riedinger, M.S.10
Zhang, W.11
Prins, R.M.12
Black, K.L.13
-
76
-
-
0142179258
-
+ T Cell Production Strongly Influences Tumor Antigen Recognition and Age-Dependent Glioma Mortality
-
Wheeler C. J., Black K. L., Liu G., Thymic CD8 + T cell production strongly influences tumor antigen recognition and age-dependent glioma mortality The Journal of Immunology 2003 171 9 4927 4933 (Pubitemid 37310617)
-
(2003)
Journal of Immunology
, vol.171
, Issue.9
, pp. 4927-4933
-
-
Wheeler, C.J.1
Black, K.L.2
Liu, G.3
Ying, H.4
Yu, J.S.5
Zhang, W.6
Lee, P.K.7
-
77
-
-
34447624543
-
Current approaches in dendritic cell generation and future implications for cancer immunotherapy
-
DOI 10.1007/s00262-007-0334-z
-
Tuyaerts S., Aerts J. L., Corthals J., Neyns B., Heirman C., Breckpot K., Thielemans K., Bonehill A., Current approaches in dendritic cell generation and future implications for cancer immunotherapy Cancer Immunology, Immunotherapy 2007 56 10 1513 1537 (Pubitemid 47094397)
-
(2007)
Cancer Immunology, Immunotherapy
, vol.56
, Issue.10
, pp. 1513-1537
-
-
Tuyaerts, S.1
Aerts, J.L.2
Corthals, J.3
Neyns, B.4
Heirman, C.5
Breckpot, K.6
Thielemans, K.7
Bonehill, A.8
-
78
-
-
40149090821
-
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas
-
Okada H., Lieberman F. S., Walter K. A., Lunsford L. D., Kondziolka D. S., Bejjani G. K., Hamilton R. L., Torres-Trejo A., Kalinski P., Cai Q., Mabold J. L., Edington H. D., Butterfield L. H., Whiteside T. L., Potter D. M., Schold S. C., Pollack I. F., Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas Journal of Translational Medicine 2007 5, article 67
-
(2007)
Journal of Translational Medicine
, vol.567
-
-
Okada, H.1
Lieberman, F.S.2
Walter, K.A.3
Lunsford, L.D.4
Kondziolka, D.S.5
Bejjani, G.K.6
Hamilton, R.L.7
Torres-Trejo, A.8
Kalinski, P.9
Cai, Q.10
Mabold, J.L.11
Edington, H.D.12
Butterfield, L.H.13
Whiteside, T.L.14
Potter, D.M.15
Schold, S.C.16
Pollack, I.F.17
-
79
-
-
53349166957
-
Prognosis of glioma patients by combined immunostaining for survivin, Ki-67 and epidermal growth factor receptor
-
Kogiku M., Ohsawa I., Matsumoto K., Sugisaki Y., Takahashi H., Teramoto A., Ohta S., Prognosis of glioma patients by combined immunostaining for survivin, Ki-67 and epidermal growth factor receptor Journal of Clinical Neuroscience 2008 15 11 1198 1203
-
(2008)
Journal of Clinical Neuroscience
, vol.15
, Issue.11
, pp. 1198-1203
-
-
Kogiku, M.1
Ohsawa, I.2
Matsumoto, K.3
Sugisaki, Y.4
Takahashi, H.5
Teramoto, A.6
Ohta, S.7
-
80
-
-
0030890836
-
Cancer vaccines based on the identification of genes encoding cancer regression antigens
-
DOI 10.1016/S0167-5699(97)84664-6, PII S0167569997010219
-
Rosenberg S. A., Cancer vaccines based on the identification of genes encoding cancer regression antigens Immunology Today 1997 18 4 175 182 (Pubitemid 27192179)
-
(1997)
Immunology Today
, vol.18
, Issue.4
, pp. 175-182
-
-
Rosenberg, S.A.1
-
81
-
-
0034919646
-
The role of MHC class II-restricted tumor antigens and CD4 + T cells in antitumor immunity
-
Wang R. F., The role of MHC class II-restricted tumor antigens and CD4 + T cells in antitumor immunity Trends in Immunology 2001 22 5 269 276
-
(2001)
Trends in Immunology
, vol.22
, Issue.5
, pp. 269-276
-
-
Wang, R.F.1
-
82
-
-
0032903599
-
Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo
-
DOI 10.1038/7403
-
Fernandez N. C., Lozier A., Flament C., Ricciardi-Castagnoli P., Bellet D., Suter M., Perricaudet M., Tursz T., Maraskovsky E., Zitvogel L., Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo Nature Medicine 1999 5 4 405 411 (Pubitemid 29180578)
-
(1999)
Nature Medicine
, vol.5
, Issue.4
, pp. 405-411
-
-
Fernandez, N.C.1
Lozier, A.2
Flament, C.3
Ricciardi-Castagnoli, P.4
Bellet, D.5
Suter, M.6
Perricaudet, M.7
Tursz, T.8
Maraskovsky, E.9
Zitvogel, L.10
-
83
-
-
58249088470
-
Reciprocal activating interaction between 6-sulfo LacNAc + dendritic cells and NK cell
-
Wehner R., Lbel B., Bornhuser M., Schkel K., Cartellieri M., Bachmann M., Rieber E. P., Schmitz M., Reciprocal activating interaction between 6-sulfo LacNAc + dendritic cells and NK cell International Journal of Cancer 2009 124 2 358 366
-
(2009)
International Journal of Cancer
, vol.124
, Issue.2
, pp. 358-366
-
-
Wehner, R.1
Lbel, B.2
Bornhuser, M.3
Schkel, K.4
Cartellieri, M.5
Bachmann, M.6
Rieber, E.P.7
Schmitz, M.8
-
84
-
-
20144380950
-
Tumoricidal potential of native blood dendritic cells: Direct tumor cell killing and activation of NK cell-mediated cytotoxicity
-
Schmitz M., Zhao S., Deuse Y., Schkel K., Wehner R., Whner H., Hlig K., Wienforth F., Kiessling A., Bornhuser M., Temme A., Rieger M. A., Weigle B., Bachmann M., Rieber E. P., Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity The Journal of Immunology 2005 174 7 4127 4134 (Pubitemid 40395990)
-
(2005)
Journal of Immunology
, vol.174
, Issue.7
, pp. 4127-4134
-
-
Schmitz, M.1
Zhao, S.2
Deuse, Y.3
Schakel, K.4
Wehner, R.5
Wohner, H.6
Holig, K.7
Wienforth, F.8
Kiessling, A.9
Bornhauser, M.10
Temme, A.11
Rieger, M.A.12
Weigle, B.13
Bachmann, M.14
Rieber, E.P.15
-
85
-
-
79955591522
-
Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy
-
Fadul C. E., Fisher J. L., Hampton T. H., Lallana E. C., Li Z., Gui J., Szczepiorkowski Z. M., Tosteson T. D., Rhodes C. H., Wishart H. A., Lewis L. D., Ernstoff M. S., Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy Journal of Immunotherapy 2011 34 4 382 389
-
(2011)
Journal of Immunotherapy
, vol.34
, Issue.4
, pp. 382-389
-
-
Fadul, C.E.1
Fisher, J.L.2
Hampton, T.H.3
Lallana, E.C.4
Li, Z.5
Gui, J.6
Szczepiorkowski, Z.M.7
Tosteson, T.D.8
Rhodes, C.H.9
Wishart, H.A.10
Lewis, L.D.11
Ernstoff, M.S.12
-
86
-
-
33644667332
-
EphA2 as a glioma-associated antigen: A novel target for glioma vaccines
-
Hatano M., Eguchi J., Tatsumi T., Kuwashima N., Dusak J. E., Kinch M. S., Pollack I. F., Hamilton R. L., Storkus W. J., Okada H., EphA2 as a glioma-associated antigen: a novel target for glioma vaccines Neoplasia 2005 7 8 717 722
-
(2005)
Neoplasia
, vol.7
, Issue.8
, pp. 717-722
-
-
Hatano, M.1
Eguchi, J.2
Tatsumi, T.3
Kuwashima, N.4
Dusak, J.E.5
Kinch, M.S.6
Pollack, I.F.7
Hamilton, R.L.8
Storkus, W.J.9
Okada, H.10
-
87
-
-
33845646732
-
Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11
-
DOI 10.1016/j.canlet.2006.01.014, PII S0304383506000620
-
Schmitz M., Wehner R., Stevanovic S., Kiessling A., Rieger M. A., Temme A., Bachmann M., Rieber E. P., Weigle B., Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11 Cancer Letters 2007 245 1-2 331 336 (Pubitemid 44959365)
-
(2007)
Cancer Letters
, vol.245
, Issue.1-2
, pp. 331-336
-
-
Schmitz, M.1
Wehner, R.2
Stevanovic, S.3
Kiessling, A.4
Rieger, M.A.5
Temme, A.6
Bachmann, M.7
Rieber, E.P.8
Weigle, B.9
-
88
-
-
3142710121
-
HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells
-
DOI 10.1158/0008-5472.CAN-03-3504
-
Liu G., Ying H., Zeng G., Wheeler C. J., Black K. L., Yu J. S., HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells Cancer Research 2004 64 14 4980 4986 (Pubitemid 38924546)
-
(2004)
Cancer Research
, vol.64
, Issue.14
, pp. 4980-4986
-
-
Liu, G.1
Ying, H.2
Zeng, G.3
Wheeler, C.J.4
Black, K.L.5
Yu, J.S.6
-
89
-
-
33845698912
-
Expression of nine tumour antigens in a series of human glioblastoma multiforme: Interest of EGFRvIII, IL-13Rα2, gp100 and TRP-2 for immunotherapy
-
DOI 10.1007/s11060-006-9220-3
-
Saikali S., Avril T., Collet B., Hamlat A., Bansard J. Y., Drenou B., Guegan Y., Quillien V., Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13R 2, gp100 and TRP-2 for immunotherapy Journal of Neuro-Oncology 2007 81 2 139 148 (Pubitemid 44963972)
-
(2007)
Journal of Neuro-Oncology
, vol.81
, Issue.2
, pp. 139-148
-
-
Saikali, S.1
Avril, T.2
Collet, B.3
Hamlat, A.4
Bansard, J.-Y.5
Drenou, B.6
Guegan, Y.7
Quillien, V.8
-
90
-
-
64949123397
-
Immunotherapeutic approaches for glioma
-
Okada H., Kohanbash G., Zhu X., Kastenhuber E. R., Hoji A., Ueda R., Fujita M., Immunotherapeutic approaches for glioma Critical Reviews in Immunology 2009 29 1 1 42
-
(2009)
Critical Reviews in Immunology
, vol.29
, Issue.1
, pp. 1-42
-
-
Okada, H.1
Kohanbash, G.2
Zhu, X.3
Kastenhuber, E.R.4
Hoji, A.5
Ueda, R.6
Fujita, M.7
-
91
-
-
39549084707
-
Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma
-
Ueda R., Low K. L., Zhu X., Fujita M., Sasaki K., Whiteside T. L., Butterfield L. H., Okada H., Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma Journal of Translational Medicine 2007 5, article 68
-
(2007)
Journal of Translational Medicine
, vol.568
-
-
Ueda, R.1
Low, K.L.2
Zhu, X.3
Fujita, M.4
Sasaki, K.5
Whiteside, T.L.6
Butterfield, L.H.7
Okada, H.8
-
92
-
-
42349107959
-
Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy
-
Zhang J. G., Kruse C. A., Driggers L., Hoa N., Wisoff J., Allen J. C., Zagzag D., Newcomb E. W., Jadus M. R., Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy Journal of Neuro-Oncology 2008 88 1 65 76
-
(2008)
Journal of Neuro-Oncology
, vol.88
, Issue.1
, pp. 65-76
-
-
Zhang, J.G.1
Kruse, C.A.2
Driggers, L.3
Hoa, N.4
Wisoff, J.5
Allen, J.C.6
Zagzag, D.7
Newcomb, E.W.8
Jadus, M.R.9
-
93
-
-
0033049977
-
Expression of MAGE and GAGE in high-grade brain tumors: A potential target for specific immunotherapy and diagnostic markers
-
Scarcella D. L., Chow C. W., Gonzales M. F., Economou C., Brasseur F., Ashley D. M., Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers Clinical Cancer Research 1999 5 2 335 341 (Pubitemid 29085187)
-
(1999)
Clinical Cancer Research
, vol.5
, Issue.2
, pp. 335-341
-
-
Scarcella, D.L.1
Chow, C.W.2
Gonzales, M.F.3
Economou, C.4
Brasseur, F.5
Ashley, D.M.6
-
94
-
-
80054689372
-
MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing
-
Bao L., Dunham K., Lucas K., MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing Cancer Immunology, Immunotherapy 2011 60 9 1299 1307
-
(2011)
Cancer Immunology, Immunotherapy
, vol.60
, Issue.9
, pp. 1299-1307
-
-
Bao, L.1
Dunham, K.2
Lucas, K.3
-
95
-
-
33846886376
-
Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics
-
2 I, DOI 10.1158/1078-0432.CCR-06-1576
-
Jian G. Z., Eguchi J., Kruse C. A., Gomez G. G., Fakhrai H., Schroter S., Ma W., Hoa N., Minev B., Delgado C., Wepsic H. T., Okada H., Jadus M. R., Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics Clinical Cancer Research 2007 13 2 566 575 (Pubitemid 46225363)
-
(2007)
Clinical Cancer Research
, vol.13
, pp. 566-575
-
-
Jian, G.Z.1
Eguchi, J.2
Kruse, C.A.3
Gomez, G.G.4
Fakhrai, H.5
Schroter, S.6
Ma, W.7
Hoa, N.8
Minev, B.9
Delgado, C.10
Wepsic, H.T.11
Okada, H.12
Jadus, M.R.13
-
96
-
-
4344706290
-
AIM-2: A novel tumor antigen is expressed and presented by human glioma cells
-
Liu G., Yu J. S., Zeng G., Yin D., Xie D., Black K. L., Ying H., AIM-2: a novel tumor antigen is expressed and presented by human glioma cells Journal of Immunotherapy 2004 27 3 220 226 (Pubitemid 39118086)
-
(2004)
Journal of Immunotherapy
, vol.27
, Issue.3
, pp. 220-226
-
-
Liu, G.1
Yu, J.S.2
Zeng, G.3
Yin, D.4
Xie, D.5
Black, K.L.6
Ying, H.7
-
97
-
-
77950461492
-
Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: A medical hypothesis paper
-
Driggers L., Zhang J. G., Newcomb E. W., Ge L., Hoa N., Jadus M. R., Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper Journal of Neuro-Oncology 2010 97 2 159 169
-
(2010)
Journal of Neuro-Oncology
, vol.97
, Issue.2
, pp. 159-169
-
-
Driggers, L.1
Zhang, J.G.2
Newcomb, E.W.3
Ge, L.4
Hoa, N.5
Jadus, M.R.6
-
98
-
-
69249149701
-
Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens
-
Xu Q., Liu G., Yuan X., Xu M., Wang H., Ji J., Konda B., Black K. L., Yu J. S., Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens Stem Cells 2009 27 8 1734 1740
-
(2009)
Stem Cells
, vol.27
, Issue.8
, pp. 1734-1740
-
-
Xu, Q.1
Liu, G.2
Yuan, X.3
Xu, M.4
Wang, H.5
Ji, J.6
Konda, B.7
Black, K.L.8
Yu, J.S.9
-
99
-
-
67650727135
-
BMI1 sustains human glioblastoma multiforme stem cell renewal
-
Abdouh M., Facchino S., Chatoo W., Balasingam V., Ferreira J., Bernier G., BMI1 sustains human glioblastoma multiforme stem cell renewal The Journal of Neuroscience 2009 29 28 8884 8896
-
(2009)
The Journal of Neuroscience
, vol.29
, Issue.28
, pp. 8884-8896
-
-
Abdouh, M.1
Facchino, S.2
Chatoo, W.3
Balasingam, V.4
Ferreira, J.5
Bernier, G.6
-
100
-
-
0035360795
-
Cyclooxygenase-2 expression in human gliomas: Prognostic significance and molecular correlations
-
Shono T., Tofilon P. J., Bruner J. M., Owolabi O., Lang F. F., Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations Cancer Research 2001 61 11 4375 4381 (Pubitemid 32685762)
-
(2001)
Cancer Research
, vol.61
, Issue.11
, pp. 4375-4381
-
-
Shono, T.1
Tofilon, P.J.2
Bruner, J.M.3
Owolabi, O.4
Lang, F.F.5
-
101
-
-
79959416877
-
Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells
-
Orzan F., Pellegatta S., Poliani P. L., Pisati F., Caldera V., Menghi F., Kapetis D., Marras C., Schiffer D., Finocchiaro G., Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells Neuropathology and Applied Neurobiology 2011 37 4 381 394
-
(2011)
Neuropathology and Applied Neurobiology
, vol.37
, Issue.4
, pp. 381-394
-
-
Orzan, F.1
Pellegatta, S.2
Poliani, P.L.3
Pisati, F.4
Caldera, V.5
Menghi, F.6
Kapetis, D.7
Marras, C.8
Schiffer, D.9
Finocchiaro, G.10
-
102
-
-
79953029992
-
Elevated invasive potential of glioblastoma stem cells
-
Cheng L., Wu Q., Guryanova O. A., Huang Z., Huang Q., Rich J. N., Bao S., Elevated invasive potential of glioblastoma stem cells Biochemical and Biophysical Research Communications 2011 406 4 643 648
-
(2011)
Biochemical and Biophysical Research Communications
, vol.406
, Issue.4
, pp. 643-648
-
-
Cheng, L.1
Wu, Q.2
Guryanova, O.A.3
Huang, Z.4
Huang, Q.5
Rich, J.N.6
Bao, S.7
-
103
-
-
77953125390
-
Influence of Etoposide on anti-apoptotic and multidrug resistance-associated protein genes in CD133 positive U251 glioblastoma stem-like cells
-
Jin F., Zhao L., Guo Y. J., Zhao W. J., Zhang H., Wang H. T., Shao T., Zhang S. L., Wei Y. J., Feng J., Jiang X. B., Zhao H. Y., Influence of Etoposide on anti-apoptotic and multidrug resistance-associated protein genes in CD133 positive U251 glioblastoma stem-like cells Brain Research 2010 1336 103 111
-
(2010)
Brain Research
, vol.1336
, pp. 103-111
-
-
Jin, F.1
Zhao, L.2
Guo, Y.J.3
Zhao, W.J.4
Zhang, H.5
Wang, H.T.6
Shao, T.7
Zhang, S.L.8
Wei, Y.J.9
Feng, J.10
Jiang, X.B.11
Zhao, H.Y.12
-
104
-
-
77956461668
-
MRP3: A molecular target for human glioblastoma multiforme immunotherapy
-
article 468
-
Kuan C. T., Wakiya K., Herndon J. E., Lipp E. S., Pegram C. N., Riggins G. J., Rasheed A., Szafranski S. E., McLendon R. E., Wikstrand C. J., Bigner D. D., MRP3: a molecular target for human glioblastoma multiforme immunotherapy BMC Cancer 2010 10, article 468
-
(2010)
BMC Cancer
, vol.10
-
-
Kuan, C.T.1
Wakiya, K.2
Herndon, J.E.3
Lipp, E.S.4
Pegram, C.N.5
Riggins, G.J.6
Rasheed, A.7
Szafranski, S.E.8
McLendon, R.E.9
Wikstrand, C.J.10
Bigner, D.D.11
-
105
-
-
79955813838
-
Neuroepithelial stem cell marker nestin regulates the migration, invasion and growth of human gliomas
-
Ishiwata T., Teduka K., Yamamoto T., Kawahara K., Matsuda Y., Naito Z., Neuroepithelial stem cell marker nestin regulates the migration, invasion and growth of human gliomas Oncology Reports 2011 26 1 91 99
-
(2011)
Oncology Reports
, vol.26
, Issue.1
, pp. 91-99
-
-
Ishiwata, T.1
Teduka, K.2
Yamamoto, T.3
Kawahara, K.4
Matsuda, Y.5
Naito, Z.6
-
106
-
-
2442669017
-
The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas
-
Ligon K. L., Alberta J. A., Kho A. T., Weiss J., Kwaan M. R., Nutt C. L., Louis D. N., Stiles C. D., Rowitch D. H., The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas Journal of Neuropathology and Experimental Neurology 2004 63 5 499 509 (Pubitemid 38669670)
-
(2004)
Journal of Neuropathology and Experimental Neurology
, vol.63
, Issue.5
, pp. 499-509
-
-
Ligon, K.L.1
Alberta, J.A.2
Kho, A.T.3
Weiss, J.4
Kwaan, M.R.5
Nutt, C.L.6
Louis, D.N.7
Stiles, C.D.8
Rowitch, D.H.9
-
107
-
-
79956363309
-
SOX2 expression and amplification in gliomas and glioma cell lines
-
Annovazzi L., Mellai M., Caldera V., Valente G., Schiffer D., SOX2 expression and amplification in gliomas and glioma cell lines Cancer Genomics and Proteomics 2011 8 3 139 147
-
(2011)
Cancer Genomics and Proteomics
, vol.8
, Issue.3
, pp. 139-147
-
-
Annovazzi, L.1
Mellai, M.2
Caldera, V.3
Valente, G.4
Schiffer, D.5
-
108
-
-
0029895337
-
Intracellular localization of cyclin B1 during the cell cycle in glioma cells
-
DOI 10.1002/(SICI)1097-0320(19960501)24:1<49::AID-CYTO6>3.0.CO;2-D
-
Kakino S., Sasaki K., Kurose A., Ito H., Intracellular localization of cyclin B1 during the cell cycle in glioma cells Cytometry 1996 24 1 49 54 (Pubitemid 26169928)
-
(1996)
Cytometry
, vol.24
, Issue.1
, pp. 49-54
-
-
Kakino, S.1
Sasaki, K.2
Kurose, A.3
Ito, H.4
-
109
-
-
79954626807
-
Catenin and Gli1 are prognostic markers in glioblastoma
-
Rossi M., Magnoni L., Miracco C., Mori E., Tosi P., Pirtoli L., Tini P., Oliveri G., Cosci E., Bakker A., -catenin and Gli1 are prognostic markers in glioblastoma Cancer Biology and Therapy 2011 11 8 753 761
-
(2011)
Cancer Biology and Therapy
, vol.11
, Issue.8
, pp. 753-761
-
-
Rossi, M.1
Magnoni, L.2
Miracco, C.3
Mori, E.4
Tosi, P.5
Pirtoli, L.6
Tini, P.7
Oliveri, G.8
Cosci, E.9
Bakker, A.10
-
110
-
-
70949087325
-
Gli1 is a potential target for alleviating multidrug resistance of gliomas
-
Cui D., Xu Q., Wang K., Che X., Gli1 is a potential target for alleviating multidrug resistance of gliomas Journal of the Neurological Sciences 2010 288 1-2 156 166
-
(2010)
Journal of the Neurological Sciences
, vol.288
, Issue.12
, pp. 156-166
-
-
Cui, D.1
Xu, Q.2
Wang, K.3
Che, X.4
-
111
-
-
79951847980
-
Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes
-
Senetta R., Miracco C., Lanzafame S., Chiusa L., Caltabiano R., Galia A., Stella G., Cassoni P., Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes Neuro-Oncology 2011 13 2 176 183
-
(2011)
Neuro-Oncology
, vol.13
, Issue.2
, pp. 176-183
-
-
Senetta, R.1
Miracco, C.2
Lanzafame, S.3
Chiusa, L.4
Caltabiano, R.5
Galia, A.6
Stella, G.7
Cassoni, P.8
-
112
-
-
0028896583
-
Overexpression and localization of cathepsin B during the progression of human gliomas
-
Sivaparvathi M., Sawaya R., Wang S. W., Rayford A., Yamamoto M., Liotta L. A., Nicolson G. L., Rao J. S., Overexpression and localization of cathepsin B during the progression of human gliomas Clinical and Experimental Metastasis 1995 13 1 49 56
-
(1995)
Clinical and Experimental Metastasis
, vol.13
, Issue.1
, pp. 49-56
-
-
Sivaparvathi, M.1
Sawaya, R.2
Wang, S.W.3
Rayford, A.4
Yamamoto, M.5
Liotta, L.A.6
Nicolson, G.L.7
Rao, J.S.8
-
113
-
-
84863241037
-
Expression of CD74 in high grade gliomas: A potential role in temozolomide resistance
-
Kitange G. J., Carlson B. L., Schroeder M. A., Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance Journal of Neuro-Oncology 2010 100 2 177 186
-
(2010)
Journal of Neuro-Oncology
, vol.100
, Issue.2
, pp. 177-186
-
-
Kitange, G.J.1
Carlson, B.L.2
Schroeder, M.A.3
-
114
-
-
78149423441
-
Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype
-
Lewis-Tuffin L. J., Rodriguez F., Giannini C., Scheithauer B., Necela B. M., Sarkaria J. N., Anastasiadis P. Z., Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype PLoS ONE 2010 5 10
-
(2010)
PLoS ONE
, vol.5
, Issue.10
-
-
Lewis-Tuffin, L.J.1
Rodriguez, F.2
Giannini, C.3
Scheithauer, B.4
Necela, B.M.5
Sarkaria, J.N.6
Anastasiadis, P.Z.7
-
115
-
-
27644466229
-
EphA2 as a novel molecular marker and target in glioblastoma multiforme
-
DOI 10.1158/1541-7786.MCR-05-0056
-
Wykosky J., Gibo D. M., Stanton C., Debinski W., EphA2 as a novel molecular marker and target in glioblastoma multiforme Molecular Cancer Research 2005 3 10 541 551 (Pubitemid 41567273)
-
(2005)
Molecular Cancer Research
, vol.3
, Issue.10
, pp. 541-551
-
-
Wykosky, J.1
Gibo, D.M.2
Stanton, C.3
Debinski, W.4
-
116
-
-
40749096452
-
Interleukin-13 receptor α2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy
-
DOI 10.1158/1078-0432.CCR-07-1990
-
Wykosky J., Gibo D. M., Stanton C., Debinski W., Interleukin-13 receptor 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy Clinical Cancer Research 2008 14 1 199 208 (Pubitemid 351377996)
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.1
, pp. 199-208
-
-
Wykosky, J.1
Gibo, D.M.2
Stanton, C.3
Debinski, W.4
-
117
-
-
12344329570
-
2) expression and intermediary filaments in astrocytic tumors
-
Mennel H. D., Lell B., Ganglioside (GD2) expression and intermediary filaments in astrocytic tumors Clinical Neuropathology 2005 24 1 13 18 (Pubitemid 40128782)
-
(2005)
Clinical Neuropathology
, vol.24
, Issue.1
, pp. 13-18
-
-
Mennel, H.D.1
Lell, B.2
-
118
-
-
0033621584
-
β1,6-N-acethylglucosamine-bearing N-glycans in human gliomas: Implications for a role in regulating invasivity
-
Yamamoto H., Swoger J., Greene S., Saito T., Hurh J., Sweeley C., Leestma J., Mkrdichian E., Cerullo L., Nishikawa A., Ihara Y., Taniguchi N., Moskal J. R., 1,6-N-acethylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity Cancer Research 2000 60 1 134 142 (Pubitemid 30058743)
-
(2000)
Cancer Research
, vol.60
, Issue.1
, pp. 134-142
-
-
Yamamoto, H.1
Swoger, J.2
Greene, S.3
Saito, T.4
Hurh, J.5
Sweeley, C.6
Leestma, J.7
Mkrdichian, E.8
Cerullo, L.9
Nishikawa, A.10
Ihara, Y.11
Taniguchi, N.12
Moskal, J.R.13
-
119
-
-
77950460434
-
Distribution, cellular localization, and therapeutic potential of the tumor-associated antigen Ku70/80 in glioblastoma multiforme
-
Persson O., Salford L. G., Fransson J., Widegren B., Borrebaeck C. A. K., Holmqvist B., Distribution, cellular localization, and therapeutic potential of the tumor-associated antigen Ku70/80 in glioblastoma multiforme Journal of Neuro-Oncology 2010 97 2 207 215
-
(2010)
Journal of Neuro-Oncology
, vol.97
, Issue.2
, pp. 207-215
-
-
Persson, O.1
Salford, L.G.2
Fransson, J.3
Widegren, B.4
Borrebaeck, C.A.K.5
Holmqvist, B.6
-
120
-
-
75949088814
-
Expression of PROX1 is a common feature of high-grade malignant astrocytic gliomas
-
Elsir T., Eriksson A., Orrego A., Lindstrm M. S., Nistér M., Expression of PROX1 is a common feature of high-grade malignant astrocytic gliomas Journal of Neuropathology and Experimental Neurology 2010 69 2 129 138
-
(2010)
Journal of Neuropathology and Experimental Neurology
, vol.69
, Issue.2
, pp. 129-138
-
-
Elsir, T.1
Eriksson, A.2
Orrego, A.3
Lindstrm, M.S.4
Nistér, M.5
-
121
-
-
79955877559
-
The prostate stem cell antigen represents a novel glioma-associated antigen
-
Geiger K. D., Hendruschk S., Rieber E. P., Morgenroth A., Weigle B., Juratli T., Senner V., Schackert G., Temme A., The prostate stem cell antigen represents a novel glioma-associated antigen Oncology Reports 2011 26 1 13 21
-
(2011)
Oncology Reports
, vol.26
, Issue.1
, pp. 13-21
-
-
Geiger, K.D.1
Hendruschk, S.2
Rieber, E.P.3
Morgenroth, A.4
Weigle, B.5
Juratli, T.6
Senner, V.7
Schackert, G.8
Temme, A.9
-
122
-
-
34548680319
-
Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B-induced gliomagenesis
-
DOI 10.1158/1541-7786.MCR-07-0113
-
Ferletta M., Uhrbom L., Olofsson T., Pontén F., Westermark B., Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-Binduced gliomagenesis Molecular Cancer Research 2007 5 9 891 897 (Pubitemid 47416666)
-
(2007)
Molecular Cancer Research
, vol.5
, Issue.9
, pp. 891-897
-
-
Ferletta, M.1
Uhrbom, L.2
Olofsson, T.3
Ponten, F.4
Westermark, B.5
-
123
-
-
9144231998
-
RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas
-
DOI 10.1038/sj.onc.1207879
-
Gondi C. S., Lakka S. S., Dinh D. H., Olivero W. C., Gujrati M., Rao J. S., RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas Oncogene 2004 23 52 8486 8496 (Pubitemid 39540799)
-
(2004)
Oncogene
, vol.23
, Issue.52
, pp. 8486-8496
-
-
Gondi, C.S.1
Lakka, S.S.2
Dinh, D.H.3
Olivero, W.C.4
Gujrati, M.5
Rao, J.S.6
-
124
-
-
33847052535
-
Mechanisms of malignant glioma immune resistance and sources of immunosuppression
-
Gomez G. G., Kruse C. A., Mechanisms of malignant glioma immune resistance and sources of immunosuppression Gene Therapy and Molecular Biology 2006 10 1 133 146 (Pubitemid 351976185)
-
(2006)
Gene Therapy and Molecular Biology
, vol.10
, Issue.1
, pp. 133-146
-
-
Gomez, G.G.1
Kruse, C.A.2
-
125
-
-
0037096733
-
Human cytomegalovirus infection and expression in human malignant glioma
-
Cobbs C. S., Harkins L., Samanta M., Gillespie G. Y., Bharara S., King P. H., Nabors L. B., Cobbs C. G., Britt W. J., Human cytomegalovirus infection and expression in human malignant glioma Cancer Research 2002 62 12 3347 3350 (Pubitemid 34651375)
-
(2002)
Cancer Research
, vol.62
, Issue.12
, pp. 3347-3350
-
-
Cobbs, C.S.1
Harkins, L.2
Samanta, M.3
Gillespie, G.Y.4
Bharara, S.5
King, P.H.6
Nabors, L.B.7
Cobbs, C.G.8
Britt, W.J.9
-
126
-
-
48249102647
-
Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate
-
Prins R. M., Cloughesy T. F., Liau L. M., Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate New England Journal of Medicine 2008 359 5 539 541
-
(2008)
New England Journal of Medicine
, vol.359
, Issue.5
, pp. 539-541
-
-
Prins, R.M.1
Cloughesy, T.F.2
Liau, L.M.3
-
127
-
-
39149136486
-
Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma
-
DOI 10.1215/15228517-2007-035
-
Mitchell D. A., Xie W., Schmittling R., Learn C., Friedman A., McLendon R. E., Sampson J. H., Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma Neuro-Oncology 2008 10 1 10 18 (Pubitemid 351250896)
-
(2008)
Neuro-Oncology
, vol.10
, Issue.1
, pp. 10-18
-
-
Mitchell, D.A.1
Xie, W.2
Schmittling, R.3
Learn, C.4
Friedman, A.5
McLendon, R.E.6
Sampson, J.H.7
-
128
-
-
51649111667
-
Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation
-
Bao L., Dunham K., Stamer M., Mulieri K. M., Lucas K. G., Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation Biology of Blood and Marrow Transplantation 2008 14 10 1156 1162
-
(2008)
Biology of Blood and Marrow Transplantation
, vol.14
, Issue.10
, pp. 1156-1162
-
-
Bao, L.1
Dunham, K.2
Stamer, M.3
Mulieri, K.M.4
Lucas, K.G.5
-
129
-
-
34250869002
-
Rapid generation of CMV pp65-specific T cells for immunotherapy
-
DOI 10.1097/CJI.0b013e31803b945b, PII 0000237120070700000010
-
Bao L., Sun Q., Lucas K. G., Rapid generation of CMV pp65-specific T cells for immunotherapy Journal of Immunotherapy 2007 30 5 557 561 (Pubitemid 46988089)
-
(2007)
Journal of Immunotherapy
, vol.30
, Issue.5
, pp. 557-561
-
-
Bao, L.1
Sun, Q.2
Lucas, K.G.3
-
130
-
-
43249131226
-
Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: A comparative study
-
DOI 10.1086/587749
-
Yao J., Bechter C., Wiesneth M., Hrter G., Gtz M., Germeroth L., Guillaume P., Hasan F., Von Harsdorf S., Mertens T., Michel D., Dhner H., Bunjes D., Schmitt M., Schmitt A., Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: a comparative study Clinical Infectious Diseases 2008 46 10 e96 e105 (Pubitemid 351706755)
-
(2008)
Clinical Infectious Diseases
, vol.46
, Issue.10
-
-
Yao, J.1
Bechter, C.2
Wiesneth, M.3
Harter, G.4
Gotz, M.5
Germeroth, L.6
Guillaume, P.7
Hasan, F.8
Von Harsdorf, S.9
Mertens, T.10
Michel, D.11
Dohner, H.12
Bunjes, D.13
Schmitt, M.14
Schmitt, A.15
-
131
-
-
79952470341
-
Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8 + T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation
-
Schmitt A., Tonn T., Busch D. H., Grigoleit G. U., Einsele H., Odendahl M., Germeroth L., Ringhoffer M., Ringhoffer S., Wiesneth M., Greiner J., Michel D., Mertens T., Rojewski M., Marx M., Von Harsdorf S., Dhner H., Seifried E., Bunjes D., Schmitt M., Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8 + T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation Transfusion 2011 51 3 591 599
-
(2011)
Transfusion
, vol.51
, Issue.3
, pp. 591-599
-
-
Schmitt, A.1
Tonn, T.2
Busch, D.H.3
Grigoleit, G.U.4
Einsele, H.5
Odendahl, M.6
Germeroth, L.7
Ringhoffer, M.8
Ringhoffer, S.9
Wiesneth, M.10
Greiner, J.11
Michel, D.12
Mertens, T.13
Rojewski, M.14
Marx, M.15
Von Harsdorf, S.16
Dhner, H.17
Seifried, E.18
Bunjes, D.19
Schmitt, M.20
more..
-
132
-
-
27544481941
-
A function for interleukin 2 in Foxp3-expressing regulatory T cells
-
DOI 10.1038/ni1263, PII N1263
-
Fontenot J. D., Rasmussen J. P., Gavin M. A., Rudensky A. Y., A function for interleukin 2 in Foxp3-expressing regulatory T cells Nature Immunology 2005 6 11 1142 1151 (Pubitemid 41541792)
-
(2005)
Nature Immunology
, vol.6
, Issue.11
, pp. 1142-1151
-
-
Fontenot, J.D.1
Rasmussen, J.P.2
Gavin, M.A.3
Rudensky, A.Y.4
-
133
-
-
33748481603
-
An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme
-
DOI 10.1215/15228517-2006-006
-
El Andaloussi A., Lesniak M. S., An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme Neuro-Oncology 2006 8 3 234 243 (Pubitemid 46542648)
-
(2006)
Neuro-Oncology
, vol.8
, Issue.3
, pp. 234-243
-
-
El Andaloussi, A.1
Lesniak, M.S.2
-
134
-
-
33645502885
-
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma
-
Fecci P. E., Mitchell D. A., Whitesides J. F., Xie W., Friedman A. H., Archer G. E., Herndon J. E., Bigner D. D., Dranoff G., Sampson J. H., Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma Cancer Research 2006 66 6 3294 3302
-
(2006)
Cancer Research
, vol.66
, Issue.6
, pp. 3294-3302
-
-
Fecci, P.E.1
Mitchell, D.A.2
Whitesides, J.F.3
Xie, W.4
Friedman, A.H.5
Archer, G.E.6
Herndon, J.E.7
Bigner, D.D.8
Dranoff, G.9
Sampson, J.H.10
-
135
-
-
52649169692
-
Incidence and prognostic impact of FoxP3 + regulatory T cells in human gliomas
-
Heimberger A. B., Abou-Ghazal M., Reina-Ortiz C., Yang D. S., Sun W., Qiao W., Hiraoka N., Fuller G. N., Incidence and prognostic impact of FoxP3 + regulatory T cells in human gliomas Clinical Cancer Research 2008 14 16 5166 5172
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.16
, pp. 5166-5172
-
-
Heimberger, A.B.1
Abou-Ghazal, M.2
Reina-Ortiz, C.3
Yang, D.S.4
Sun, W.5
Qiao, W.6
Hiraoka, N.7
Fuller, G.N.8
-
136
-
-
54949139265
-
The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation
-
Annunziato F., Cosmi L., Liotta F., Maggi E., Romagnani S., The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation International Immunology 2008 20 11 1361 1368
-
(2008)
International Immunology
, vol.20
, Issue.11
, pp. 1361-1368
-
-
Annunziato, F.1
Cosmi, L.2
Liotta, F.3
Maggi, E.4
Romagnani, S.5
-
138
-
-
47649122633
-
Tumor-specific Th17-polarized cells eradicate large established melanoma
-
Muranski P., Boni A., Antony P. A., Cassard L., Irvine K. R., Kaiser A., Paulos C. M., Palmer D. C., Touloukian C. E., Ptak K., Gattinoni L., Wrzesinski C., Hinrichs C. S., Kerstann K. W., Feigenbaum L., Chan C. C., Restifo N. P., Tumor-specific Th17-polarized cells eradicate large established melanoma Blood 2008 112 2 362 373
-
(2008)
Blood
, vol.112
, Issue.2
, pp. 362-373
-
-
Muranski, P.1
Boni, A.2
Antony, P.A.3
Cassard, L.4
Irvine, K.R.5
Kaiser, A.6
Paulos, C.M.7
Palmer, D.C.8
Touloukian, C.E.9
Ptak, K.10
Gattinoni, L.11
Wrzesinski, C.12
Hinrichs, C.S.13
Kerstann, K.W.14
Feigenbaum, L.15
Chan, C.C.16
Restifo, N.P.17
-
139
-
-
78149453343
-
The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human gliom
-
Wainwright D. A., Sengupta S., Han Y., Ulasov I. V., Lesniak M. S., The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human gliom PLoS ONE 2010 5 10
-
(2010)
PLoS ONE
, vol.5
, Issue.10
-
-
Wainwright, D.A.1
Sengupta, S.2
Han, Y.3
Ulasov, I.V.4
Lesniak, M.S.5
-
140
-
-
77954641353
-
Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties
-
Rodrigues J. C., Gonzalez G. C., Zhang L., Ibrahim G., Kelly J. J., Gustafson M. P., Lin Y., Dietz A. B., Forsyth P. A., Yong V. W., Parney I. F., Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties Neuro-Oncology 2010 12 4 351 365
-
(2010)
Neuro-Oncology
, vol.12
, Issue.4
, pp. 351-365
-
-
Rodrigues, J.C.1
Gonzalez, G.C.2
Zhang, L.3
Ibrahim, G.4
Kelly, J.J.5
Gustafson, M.P.6
Lin, Y.7
Dietz, A.B.8
Forsyth, P.A.9
Yong, V.W.10
Parney, I.F.11
-
141
-
-
79960003585
-
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
-
Raychaudhuri B., Rayman P., Ireland J., Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma Neuro-Oncology 2011 13 6 591 599
-
(2011)
Neuro-Oncology
, vol.13
, Issue.6
, pp. 591-599
-
-
Raychaudhuri, B.1
Rayman, P.2
Ireland, J.3
-
143
-
-
33845317573
-
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
-
DOI 10.1038/nature05236, PII NATURE05236
-
Bao S., Wu Q., McLendon R. E., Hao Y., Shi Q., Hjelmeland A. B., Dewhirst M. W., Bigner D. D., Rich J. N., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 2006 444 7120 756 760 (Pubitemid 44949604)
-
(2006)
Nature
, vol.444
, Issue.7120
, pp. 756-760
-
-
Bao, S.1
Wu, Q.2
McLendon, R.E.3
Hao, Y.4
Shi, Q.5
Hjelmeland, A.B.6
Dewhirst, M.W.7
Bigner, D.D.8
Rich, J.N.9
-
144
-
-
33845671339
-
Analysis of gene expression and chemoresistance of CD133 + cancer stem cells in glioblastoma
-
Liu G., Yuan X., Zeng Z., Tunici P., Ng H., Abdulkadir I. R., Lu L., Irvin D., Black K. L., Yu J. S., Analysis of gene expression and chemoresistance of CD133 + cancer stem cells in glioblastoma Molecular Cancer 2006 5, article 67
-
(2006)
Molecular Cancer
, vol.567
-
-
Liu, G.1
Yuan, X.2
Zeng, Z.3
Tunici, P.4
Ng, H.5
Abdulkadir, I.R.6
Lu, L.7
Irvin, D.8
Black, K.L.9
Yu, J.S.10
-
145
-
-
0141842674
-
Identification of a cancer stem cell in human brain tumors
-
Singh S. K., Clarke I. D., Terasaki M., Bonn V. E., Hawkins C., Squire J., Dirks P. B., Identification of a cancer stem cell in human brain tumors Cancer Research 2003 63 18 5821 5828 (Pubitemid 37187480)
-
(2003)
Cancer Research
, vol.63
, Issue.18
, pp. 5821-5828
-
-
Singh, S.K.1
Clarke, I.D.2
Terasaki, M.3
Bonn, V.E.4
Hawkins, C.5
Squire, J.6
Dirks, P.B.7
-
146
-
-
77953143517
-
Glioma cell populations grouped by different cell type markers drive brain tumor growth
-
Prestegarden L., Svendsen A., Wang J., Sleire L., Skaftnesmo K. O., Bjerkvig R., Yan T., Askland L., Persson A., Sakariassen P.., Enger P.., Glioma cell populations grouped by different cell type markers drive brain tumor growth Cancer Research 2010 70 11 4274 4279
-
(2010)
Cancer Research
, vol.70
, Issue.11
, pp. 4274-4279
-
-
Prestegarden, L.1
Svendsen, A.2
Wang, J.3
Sleire, L.4
Skaftnesmo, K.O.5
Bjerkvig, R.6
Yan, T.7
Askland, L.8
Persson, A.9
Sakariassen, P.10
Enger, P.11
-
147
-
-
33751297619
-
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas
-
DOI 10.1158/0008-5472.CAN-06-2048
-
Pellegatta S., Poliani P. L., Corno D., Menghi F., Ghielmetti F., Suarez-Merino B., Caldera V., Nava S., Ravanini M., Facchetti F., Bruzzone M. G., Finocchiaro G., Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas Cancer Research 2006 66 21 10247 10252 (Pubitemid 44799739)
-
(2006)
Cancer Research
, vol.66
, Issue.21
, pp. 10247-10252
-
-
Pellegatta, S.1
Poliani, P.L.2
Corno, D.3
Menghi, F.4
Ghielmetti, F.5
Suarez-Merino, B.6
Caldera, V.7
Nava, S.8
Ravanini, M.9
Facchetti, F.10
Bruzzone, M.G.11
Finocchiaro, G.12
-
148
-
-
78650098659
-
Glioblastoma stem-like cells give rise to tumour endothelium
-
Wang R., Chadalavada K., Wilshire J., Kowalik U., Hovinga K. E., Geber A., Fligelman B., Leversha M., Brennan C., Tabar V., Glioblastoma stem-like cells give rise to tumour endothelium Nature 2010 468 7325 829 835
-
(2010)
Nature
, vol.468
, Issue.7325
, pp. 829-835
-
-
Wang, R.1
Chadalavada, K.2
Wilshire, J.3
Kowalik, U.4
Hovinga, K.E.5
Geber, A.6
Fligelman, B.7
Leversha, M.8
Brennan, C.9
Tabar, V.10
-
149
-
-
78650153633
-
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
-
Ricci-Vitiani L., Pallini R., Biffoni M., Todaro M., Invernici G., Cenci T., Maira G., Parati E. A., Stassi G., Larocca L. M., De Maria R., Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells Nature 2010 468 7325 824 830
-
(2010)
Nature
, vol.468
, Issue.7325
, pp. 824-830
-
-
Ricci-Vitiani, L.1
Pallini, R.2
Biffoni, M.3
Todaro, M.4
Invernici, G.5
Cenci, T.6
Maira, G.7
Parati, E.A.8
Stassi, G.9
Larocca, L.M.10
De Maria, R.11
-
150
-
-
18344375283
-
Immunotherapy and chemotherapyapractical partnership
-
Lake R. A., Robinson B. W. S., Immunotherapy and chemotherapyapractical partnership Nature Reviews Cancer 2005 5 5 397 405
-
(2005)
Nature Reviews Cancer
, vol.5
, Issue.5
, pp. 397-405
-
-
Lake, R.A.1
Robinson, B.W.S.2
-
151
-
-
33646351049
-
Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancer
-
DOI 10.1002/ijc.21681
-
Bourquin C., Schreiber S., Beck S., Hartmann G., Endres S., Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancer International Journal of Cancer 2006 118 11 2790 2795 (Pubitemid 43673358)
-
(2006)
International Journal of Cancer
, vol.118
, Issue.11
, pp. 2790-2795
-
-
Bourquin, C.1
Schreiber, S.2
Beck, S.3
Hartmann, G.4
Endres, S.5
-
152
-
-
35948930300
-
Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma
-
Kim C. H., Woo S. J., Park J. S., Kim H. S., Park M. Y., Park S. D., Hong Y. K., Kim T. G., Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma Immunology 2007 122 4 615 622
-
(2007)
Immunology
, vol.122
, Issue.4
, pp. 615-622
-
-
Kim, C.H.1
Woo, S.J.2
Park, J.S.3
Kim, H.S.4
Park, M.Y.5
Park, S.D.6
Hong, Y.K.7
Kim, T.G.8
-
153
-
-
84863115788
-
Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8 + T cells
-
Xu X., Stockhammer F., Schmitt A., Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8 + T cells International Journal of Oncology 40 3 764 772
-
International Journal of Oncology
, vol.40
, Issue.3
, pp. 764-772
-
-
Xu, X.1
Stockhammer, F.2
Schmitt, A.3
|